NCT00207727View on ClinicalTrials.gov

A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

August 31, 2006

Conditions
Multiple Sclerosis
Interventions
DRUG

CNTO 1275

Sponsors

Lead Sponsor

Centocor, Inc.

Collaborators (1)

Centocor BV
All Listed Sponsors
collaborator

Centocor BV

INDUSTRY

lead

Centocor, Inc.

INDUSTRY